Citigroup’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.09M | Buy |
317,882
+28,553
| +10% | +$457K | ﹤0.01% | 1399 |
|
|
2025
Q1 | $4.94M | Buy |
289,329
+147,011
| +103% | +$2.51M | ﹤0.01% | 1401 |
|
|
2024
Q4 | $3.53M | Buy |
142,318
+48,980
| +52% | +$1.21M | ﹤0.01% | 1699 |
|
|
2024
Q3 | $2.66M | Buy |
93,338
+61,743
| +195% | +$1.76M | ﹤0.01% | 1823 |
|
|
2024
Q2 | $834K | Sell |
31,595
-218,196
| -87% | -$5.76M | ﹤0.01% | 2374 |
|
|
2024
Q1 | $8.07M | Buy |
249,791
+125,449
| +101% | +$4.05M | 0.01% | 988 |
|
|
2023
Q4 | $5.24M | Sell |
124,342
-1,974
| -2% | -$83.2K | ﹤0.01% | 1106 |
|
|
2023
Q3 | $4.85M | Buy |
126,316
+38,179
| +43% | +$1.47M | ﹤0.01% | 1050 |
|
|
2023
Q2 | $1.67M | Sell |
88,137
-197,230
| -69% | -$3.74M | ﹤0.01% | 1834 |
|
|
2023
Q1 | $4.43M | Buy |
285,367
+182,796
| +178% | +$2.84M | ﹤0.01% | 1163 |
|
|
2022
Q4 | $1.82M | Buy |
102,571
+99,612
| +3,366% | +$1.77M | ﹤0.01% | 1587 |
|
|
2022
Q3 | $17K | Sell |
2,959
-2,716
| -48% | -$15.6K | ﹤0.01% | 4076 |
|
|
2022
Q2 | $22K | Buy |
5,675
+353
| +7% | +$1.37K | ﹤0.01% | 4243 |
|
|
2022
Q1 | $29K | Sell |
5,322
-149,177
| -97% | -$813K | ﹤0.01% | 4243 |
|
|
2021
Q4 | $1.32M | Sell |
154,499
-120,550
| -44% | -$1.03M | ﹤0.01% | 2289 |
|
|
2021
Q3 | $2.39M | Sell |
275,049
-44,829
| -14% | -$390K | ﹤0.01% | 1779 |
|
|
2021
Q2 | $3.38M | Buy |
319,878
+77,257
| +32% | +$817K | ﹤0.01% | 1726 |
|
|
2021
Q1 | $3.89M | Buy |
242,621
+224,559
| +1,243% | +$3.6M | ﹤0.01% | 1501 |
|
|
2020
Q4 | $834K | Buy |
18,062
+15,867
| +723% | +$733K | ﹤0.01% | 2296 |
|
|
2020
Q3 | $77K | Sell |
2,195
-10,885
| -83% | -$382K | ﹤0.01% | 3270 |
|
|
2020
Q2 | $318K | Buy |
13,080
+11,452
| +703% | +$278K | ﹤0.01% | 2827 |
|
|
2020
Q1 | $25K | Buy |
+1,628
| New | +$25K | ﹤0.01% | 4245 |
|